A Aralex Aachen research explorer

April 19, 2023 article

Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti–Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer

Journal of Clinical Oncology

DOI: 10.1200/jco.22.02241 OpenAlex

Authors 0

Author list not loaded yet.

Cited by 2 stored of 107

GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer
2024 npj Breast Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access

2

citations
Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE)
2024 ESMO Open article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access

6

citations

2 results

References 0